Insider Transactions in Q2 2023 at Inspire Medical Systems, Inc. (INSP)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 26
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-3.78%
|
$166,635
$315.87 P/Share
|
|
Jun 26
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+12.46%
|
$16,000
$16.0 P/Share
|
|
Jun 20
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-4.05%
|
$162,403
$307.64 P/Share
|
|
Jun 20
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+13.24%
|
$16,000
$16.0 P/Share
|
|
Jun 12
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-4.37%
|
$163,461
$309.03 P/Share
|
|
Jun 12
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+14.12%
|
$16,000
$16.0 P/Share
|
|
Jun 05
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-4.74%
|
$161,345
$305.69 P/Share
|
|
Jun 05
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+15.12%
|
$16,000
$16.0 P/Share
|
|
May 30
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-5.17%
|
$155,526
$294.9 P/Share
|
|
May 30
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+16.28%
|
$16,000
$16.0 P/Share
|
|
May 22
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-5.7%
|
$162,403
$307.52 P/Share
|
|
May 22
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+17.63%
|
$16,000
$16.0 P/Share
|
|
May 15
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-6.34%
|
$154,997
$293.91 P/Share
|
|
May 15
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+19.23%
|
$16,000
$16.0 P/Share
|
|
May 12
2023
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
4,525
-20.94%
|
$1,321,300
$292.86 P/Share
|
|
May 12
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,525
+33.72%
|
$321,275
$71.0 P/Share
|
|
May 08
2023
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
529
-7.15%
|
$148,120
$280.0 P/Share
|
|
May 08
2023
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+21.15%
|
$16,000
$16.0 P/Share
|
|
May 08
2023
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
1,727
-28.32%
|
$483,560
$280.12 P/Share
|
|
May 08
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,727
+22.07%
|
$72,534
$42.15 P/Share
|
|
Apr 27
2023
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+3.2%
|
-
|
|
Apr 27
2023
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+34.36%
|
-
|
|
Apr 27
2023
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
669
+44.69%
|
-
|
|
Apr 27
2023
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+18.27%
|
-
|
|
Apr 27
2023
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+3.14%
|
-
|
|
Apr 27
2023
|
Jerry C Griffin Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+19.69%
|
-
|
|
Apr 27
2023
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+12.03%
|
-
|
|
Apr 27
2023
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+37.67%
|
-
|
|
Apr 27
2023
|
Shawn Mc Cormick Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+5.2%
|
-
|
|
Apr 27
2023
|
Cynthia Burks Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+50.0%
|
-
|
|
Apr 25
2023
|
Steven Jandrich VP, Human Resources |
SELL
Open market or private sale
|
Direct |
8,000
-27.58%
|
$2,168,000
$271.49 P/Share
|
|
Apr 25
2023
|
Steven Jandrich VP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+39.27%
|
$336,000
$42.15 P/Share
|
|
Apr 10
2023
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+0.28%
|
$12,936
$231.77 P/Share
|
|
Apr 10
2023
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+2.68%
|
$14,784
$231.77 P/Share
|
|
Apr 10
2023
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
64
+9.51%
|
$14,784
$231.77 P/Share
|
|
Apr 10
2023
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+2.11%
|
$21,021
$231.77 P/Share
|
|
Apr 10
2023
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+11.87%
|
$13,629
$231.77 P/Share
|
|
Apr 10
2023
|
Charisse Y Sparks Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56
+26.05%
|
$12,936
$231.77 P/Share
|